麦克-1缺陷通过抑制巨细胞极化和激活来改善压力过载心力衰竭
Qiu-Yue Lin1, Wei-Jia Yu1, Jie Bai2
1Institute of Cardiovascular Diseases, First Affiliated Hospital of Dalian Medical University, Dalian, China.
Biochimica et biophysica acta. Molecular basis of disease
|January 31, 2024
概括
巨细胞-1抗原 (Mac-1) 缺乏改善了压力过载后的心脏重塑和功能障碍. 麦克-1淘汰赛小鼠显示心力衰竭减少,这表明麦克-1抑制是潜在的治疗策略.
科学领域:
- 心血管生物学 心血管生物学
- 免疫学 免疫学 免疫学
- 病理学 病理学 病理学
背景情况:
- 持续的压力过载会导致病态的心脏缩,重塑和心力衰竭 (HF).
- 免疫细胞的参与和炎症是心脏重塑病变发生的关键.
- 大细胞-1抗原 (Mac-1) 调节白细胞迁移和两极分化,但其在压力过载引起的心脏重塑中的作用尚不清楚.
研究的目的:
- 调查Mac-1在心脏重塑和压力过载引起的心力衰竭中的作用.
- 确定Mac-1缺陷对心脏功能和病理反应的作用,以应对横向大动脉收缩 (TAC).
主要方法:
- 巨1抗原淘汰赛 (KO) 和野生型 (WT) 小鼠接受了6周的TAC.
- 用心声谱和压力-体积循环分析来评估心脏功能.
- 心脏重塑,巨细胞透和两极分化通过病原体学和分子技术进行了评估.
主要成果:
- 在TAC处理的心脏中,Mac-1表达显著增加.
- 与WT小鼠相比,Mac-1-KO小鼠表现出显著改善的心脏功能和减少的缩,纤维化,氧化应激和亡.
- 麦克-1缺乏抑制了巨细胞的透和M1极化,与改变的NF-kB,STAT1和STAT6表达相关.
结论:
- 麦克-1 缺陷可以防止患有病态心脏重塑和因压力过重而引起的心力衰竭.
- 抑制Mac-1为治疗心力衰竭提供了潜在的治疗途径.
相关概念视频
Pathophysiology of Heart Failure
1.6K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.6K
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
431
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
431


